News

The Cost of Delaying A Trial

From discovery and development through to market, the life cycle of new medicine is a profoundly complex process, frequently met with obstacles. Research produced by PhRMA found that clinical trials take on average six to seven years to assess safety and efficiency, with the overall probability of success less than 12%.

Read more
Quality Assurance: The Key to Every Successful Clinical Trial

Quality is an essential element that underpins every aspect of a clinical trial. As an industry, we easily understand the benefits of quality monitoring to ensure quality data and clinical trial management. However, we often underestimate or do not understand the broader Quality Assurance (QA) function and how a well-trained team of QA auditors can ensure successful trial outcomes.

Read more
How to Run A Trial During a Pandemic

When the pandemic hit, it was like someone stuck a stick through the wheels of a bike, and we all went toppling over. Everyone had the intention to keep moving, keep peddling forward, but the uncertainty of COVID-19 felt like a heavy burden.

Read more
New Zealand: A Promising Destination For Trials in A Post-Covid-19 World? [Pharmaceutical Technology]

Unlike the rest of the world, New Zealand’s speedy and decisive response to Covid-19 has successfully enabled the country’s clinical trials to continue largely unscathed. Allie Nawrat talks to key actors in the New Zealand clinical space about how Covid-1.

Read more
Successful Patient Recruitment In a COVID-19 World

Pharmaceutical Solutions (PSL), which is New Zealand and Australia-based, has been geographically fortunate, and our proven strategies have also ensured the continuation and success of our clinical studies.

Read more
Rapid Study Startup and High Patient Recruitment for US Biotech Clinical Trial

A US-based biotech company was seeking a CRO who could successfully recruit a large number of elderly patients in New Zealand. A challenge squeezed into a three-month recruitment window.

Read more
Covid-19: New Zealand's response rated best in the world [Bloomberg]

New Zealand is the best place in the world to be in the coronavirus era, according to the new Bloomberg Covid resilience ranking.

Read more
BetterLife Pharma chooses Pharmaceutical Solutions CRO for Australia coronavirus trial of AP-003

The company has selected Pharmaceutical Solutions Ltd, which specializes in managing clinical trials in Australia and New Zealand.

Read more
“I wanted to be part of the solution to Covid-19”: Michele Ashby, Executive Director, US

We’re incredibly proud of our Executive Director of Business Development in the United States, Michele Ashby, who is taking part in a US based COVID-19 vaccine trial. Hear from Michele, her insights as a clinical trial participant.

Read more
Pharmaceutical Solutions: Quality Assurance in Clinical Trials

With international travel restrictions in place, many pharmaceutical/biotech/CRO companies have had to place quality assurance audits for their clinical trials on hold.

Read more
Assured Continuity of Clinical Trials in Australia and New Zealand during the Covid-19 pandemic

Confidence in the Australian and New Zealand clinical environment has been shown globally with 170 new study start-ups registered on the ANZCTR between April and August 2019

Read more
2020 Finalist - Westpac Business Awards

​Pharmaceutical Solutions is honoured to be selected as a finalist in the Westpac Auckland Business Awards - Excellence in International Trade category.

Read more
Clinical trial continuity in NZ: Optimal Clinical Trials

Clinical trials are considered an essential service by the New Zealand Government and so can continue to operate at all alert levels

Read more
Moving forward, together

After 102 days, New Zealand has recorded its first new cases of community transmission of Covid-19. As of midday on Wednesday 12th Aug, there are only four cases confirmed, all of which are in Auckland.

Read more
COVID-19 and New Zealand’s clinical research sector [NZ Herald.co.nz]

"In the global race to find a vaccine, we need populations that have had little exposure to Covid-19 and New Zealand can offer a vital link in the global effort to halt the novel coronavirus," said the group's managing director, Jacquie Palmer.”

Read more
Clinical trials in NZ worth $1.2 billion: Medicines NZ

New Zealand has a window of opportunity to increase market share. Chief executive of Medicines NZ, Graeme Jarvis, says there has to be a collaborative effort between the industry, clinical research sector and government to make New Zealand a bigger player on the world stage.

Read more
Medicines NZ report estimates clinical trials worth $1.2b over 5 years

A new report independently commissioned by Medicines New Zealand estimates that since 2013, clinical trials of prescription medicines have contributed at least $1.2 billion to the New Zealand economy and have benefitted the health system and Kiwi patients.

Read more